| Speech Pathology Enrichment Language & Literacy Clinic | |
|
4050 Lake Otis Pkwy, Suite 204-c, Anchorage, AK 99508-5223 | |
| (907) 336-7323 | |
| (907) 277-7355 |
| Full Name | Speech Pathology Enrichment Language & Literacy Clinic |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 4050 Lake Otis Pkwy, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801129994 | NPI | - | NPPES |
| SP0003 | Medicaid | AK | |
| SP5061 | Medicaid | AK | |
| SP6595 | Medicaid | AK |
| Mailing Address | Practice Location Address |
|---|---|
| Speech Pathology Enrichment Language & Literacy Clinic 4050 Lake Otis Pkwy, Suite 204-c, Anchorage, AK 99508-5223 Ph: (907) 336-7323 | Speech Pathology Enrichment Language & Literacy Clinic 4050 Lake Otis Pkwy, Suite 204-c, Anchorage, AK 99508-5223 Ph: (907) 336-7323 |
News Archive
Patients with certain gene variants who were prescribed beta-blocker drugs after acute coronary syndrome (ACS) had an increased risk of death over the next three years, according to a study in the September 28 issue of Journal of the American Medical Association (JAMA).
Researchers at the Eastern Virginia Medical School Strelitz Diabetes Center have been awarded a $1,076,250 grant by the Department of Defense Peer Reviewed Medical Research Program to develop new ways of reversing the underlying causes of Type 1 diabetes.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
Researchers funded by the National Institutes of Health have launched an effort to evaluate drugs prescribed to treat COVID-19 in infants, children and adolescents across the country. The study leverages an existing clinical trial that examines drugs that are prescribed off-label to children for a variety of medical conditions.
› Verified 4 days ago
Kathryn Cross, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12350 Industry Way, 202, Anchorage, AK 99515 Phone: 907-301-4588 | |
Tracey Keaton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6927 Old Seward Hwy Ste 100, Anchorage, AK 99518 Phone: 907-345-0050 | |
Christal Hays, MS CCC SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-8800 | |
Mrs. Lisa J.c. Rayes, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4048 Laurel St Ste 303, Anchorage, AK 99508 Phone: 907-562-4550 | |
Lian Liew Tan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4155 Tudor Centre Dr, Suite #103, Anchorage, AK 99508 Phone: 907-854-8624 | |
Mrs. Yvonne Marie San Juan, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4241 B St Ste 301, Anchorage, AK 99503 Phone: 907-727-0935 Fax: 907-276-7529 | |
Speak From The Heart Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3351 W 84th Ave, Anchorage, AK 99502 Phone: 907-390-0492 |